AstraZeneca PLC has denied speculation that it is in negotiations with the White House about a potential emergency use authorization of its COVID-19 vaccine candidate ahead of the US presidential elections in November.
The company has responded to claims made in the Financial Times on 23 August, the same day that the US...







